The Recall Desk
CriticalFDA (Drugs)·D-1372-2014·Announced 2014-06-18

Jianfeijindan Activity Girl Capsules Recalled for Undeclared Sibutramine Analog

MyNicNaxs, Inc. is recalling Jianfeijindan Activity Girl Capsules because they contain an undeclared sibutramine analog and were marketed without FDA approval.

What this means for you

Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.

Our severity reasoning: The agency classification is FDA Class I, which mandates a severity score of 5 according to the rubric.

Plain-English summary

MyNicNaxs, Inc. is recalling Jianfeijindan Activity Girl Capsules, 400 mg, supplied in 30 count boxes. The product was distributed by MyNicKnaxs, LLC, in Deltona, Florida, and was available nationwide.

The recall was initiated because the product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). Additionally, the product was found to contain an undeclared ingredient: N-di-desmethylsibutramine, which is an analog of sibutramine.

Consumers who possess this product should stop using it immediately and contact the recalling firm for instructions on how to return or dispose of the product.

The recalled product

Product
JIANFEIJINDAN Activity Girl Capsules, 400 mg, supplied in 30 count boxes, distributed by MyNicKnaxs, LLC, Deltona, FL
Manufacturer
MyNicNaxs, Inc.

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • ALL LOTS

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 10 recalled by MyNicNaxs, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 10 products in this recall →